Copyright
©The Author(s) 2017.
World J Gastrointest Endosc. Sep 16, 2017; 9(9): 471-479
Published online Sep 16, 2017. doi: 10.4253/wjge.v9.i9.471
Published online Sep 16, 2017. doi: 10.4253/wjge.v9.i9.471
Table 1 Descriptive statistics of demographic and medication variables for patients receiving different analgesia/sedation regimes
| Variable | Type of analgesia/sedation | ||
| Midazolam ± opioid | Entonox ± opioid | Unmedicated | |
| Gender | |||
| Female (% of females) | 6753 (76.0%) | 1609 (18.1%) | 520 (5.9%) |
| Male (% of males) | 4613 (56.1%) | 2239 (27.2%) | 1373 (16.7%) |
| Median age/yr (IQR) | 61.1 (50.7-70.1) | 60.4 (50.8-69.1) | 63.8 (54.3-71.4) |
| Median midazolam dose/mg (IQR) | 2.5 (2.0-3.0) | ||
| Opioid, mcg | |||
| Number (%) given fentanyl | 10255 (90.2%) | 258 (6.7%) | 0 (0.0%) |
| Number (%) given pethidine | 1060 (9.3%) | 27 (0.7%) | 0 (0.0%) |
| Total number (%) given an opioid | 11299 (99.4%) | 284 (7.4%) | 0 (0.0%) |
| Median fentanyl equivalent dose (IQR) | 75.0 (50.0-100.0) | 75.0 (50.0-100.0) | |
- Citation: Robertson AR, Kennedy NA, Robertson JA, Church NI, Noble CL. Colonoscopy quality with Entonox®vs intravenous conscious sedation: 18608 colonoscopy retrospective study. World J Gastrointest Endosc 2017; 9(9): 471-479
- URL: https://www.wjgnet.com/1948-5190/full/v9/i9/471.htm
- DOI: https://dx.doi.org/10.4253/wjge.v9.i9.471